Arrigo A,Calamuneri A,Milardi D,Mormina E,Rania L,Postorino E,Marino S,Di Lorenzo G,Anastasi GP,Ghilardi MF,Aragona P,Quartarone A,Gaeta M .2017 .Visual system involvement in patients with newly diagnosed Parkinson's disease. Radiology, 285(3) : 885-895.
Bledsoe IO,Stebbins GT,Merkitch D,Goldman JG .2018 .White matter abnormalities in the corpus callosum with cognitive impairment in Parkinson disease. Neurology, 91(24) : e2244-e2255.
Costa-Mallen P,Gatenby C,Friend S,Maravilla KR,Hu SC,Cain KC,Agarwal P,Anzai Y .2017 .Brain iron concentrations in regions of interest and relation with serum iron levels in Parkinson's disease. J. Neurol. Sci., 378 : 38-44.
Dadar M,Zeighami Y,Yau Y,Fereshtehnejad SM,Maranzano J,Postuma RB,Dagher A,Collins DL .2018 .White matter hyperintensities are linked to future cognitive decline in de novo Parkinson's disease patients. Neuroimage Clin., 20 : 892-900.
Ji GJ,Ren C,Li Y,Sun J,Liu T,Gao Y,Xue D,Shen L,Cheng W,Zhu C,Tian Y,Hu P,Chen X,Wang K X .2019 .Regional and network properties of white matter function in Parkinson's disease. Hum. Brain Mapp, 40(4) : 1253-1263.
Ly H,Verma N,Wu F,Liu M,Saatman KE,Nelson PT,Slevin JT,Goldstein LB,Biessels GJ,Despa F GJ .2017 .Brain microvascular injury and white matter disease provoked by diabetes-associated hyperamylinemia. , 82(2) : 208-222.
Malak ALSB,Vasconcellos LF,Pereira JS,Greca DV,Cruz M,Alves HVD,Sptiz M,CharchatFichman H M .2017 .Symptoms of depression in patients with mild cognitive impairment in Parkinson's disease. Dement Neuropsychol, 11(2) : 145-153.
Rektor I,Svátková A,Vojtíšek L,Zikmundová I,Vaníček J,Király A,Szabó N A .2018 .White matter alterations in Parkinson's disease with normal cognition precede grey matter atrophy. PLoS One, 13(1) : e0187939.
Sterling NW,Du G,Lewis MM,Swavely S,Kong L,Styner M,Huang X .2017 .Cortical gray and subcortical white matter associations in Parkinson's disease. Neurobiol. Aging, 49 : 100-108.
Ten Harmsen BL,van Rumund A,Aerts MB,Bergkamp MI,Esselink RAJ,Richard E,Meijer FJA,Bloem BR .2018 .Clinical correlates of cerebral white matter abnormalities in patients with Parkinson's disease. Parkinsonism Relat, 49 : 28-33.
Wang X,Li R,Zacharek A,Landschoot-Ward J,Chopp M,Chen J,Cui X .2019 .ApoA-I mimetic peptide reduces vascular and white matter damage after stroke in type-2 diabetic mice. Front Neurosci., 13 : 1127.
Winer JR,Maass A,Pressman P,Stiver J,Schonhaut DR,Baker SL,Kramer J,Rabinovici GD,Jagust WJ,Amyloid WJ .2018 .and cognition in parkinson disease. JAMA Neurol, 75(2) : 227-235.
Yau Y,Zeighami Y,Baker TE,Larcher K,Vainik U,Dadar M,Fonov VS,Hagmann P,Griffa A,Mišić B,Collins DL,Dagher A .2018 .Network connectivity determines cortical thinning in early Parkinson's disease progression. Nat. Commun, 9(1) : 12.